Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06389058 · ClinicalTrials.gov registry record
Using NLP and Neural Networks to Autonomously Identify Severe Asthma and Determine Study Eligibility in a Large Healthcare System
A clinical trial of Severe Asthma, sponsored by San Diego State University.
- Active
- Registry status
- 31,795
- Enrollment target
- 1
- Study location
NCT06389058: Active study of Severe Asthma, sponsored by San Diego State University.
NCT06389058 is a study of Severe Asthma that is active but no longer recruiting, run by San Diego State University. The registered enrollment target is 31,795 participants, above the 322-participant average among 9 other Severe Asthma trials with a reported enrollment target (9774% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06389058, a study of Severe Asthma, is active but no longer recruiting, sponsored by San Diego State University.
- ACTIVE NOT RECRUITING
- Registry status
- 31,795 participants
- Enrollment target
- 1
- Study location
Study Summary
The study aims to to use new technologies (ML, AI, NLP), to autonomously identify moderate to severe asthma populations within an EHR system, describe differences in treatment patterns across different populations, and determine trial eligibility. Primary Objectives Please ensure you detail primary objectives Aim 1. Determine and validate a diagnosis of severe asthma (SA) using predictive features obtained from the Scripps Health EHR. * Aim 1a: Use ML applied to structured EHR data to predict SA. Use the opinion of 2 specialty-trained physicians and ATS guidelines to determine model accuracy. * Aim 1b: Use NLP applied to unstructured text to predict SA. Determine model accuracy as above in Aim 1a. * Aim 1c: Use a combination of ML applied to structured data to predict SA. Determine model accuracy as above in Aim 1a.
Primary Outcome
Identify patients with severe asthma and compare diagnoses to that of medical professionals
Conditions Studied
Interventions
- OTHER Recommendation for the diagnoses and treatment of Severe Asthma
Study Locations (1)
California
- San Diego State University - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31,795 participants |
| Start Date | 2023-05-01 |
| Est. Completion | 2026-03 |
What the registry record for NCT06389058 still lists
NCT06389058 is an observational study that tracks outcomes without assigning an intervention. Its 31,795 participants enrollment target places it among the larger protocols in the corpus, above the 322-participant average among 9 other Severe Asthma trials with a reported enrollment target (9774% higher).
The record links to 1 condition, with Severe Asthma appearing as the primary indexed condition, and to 1 intervention - of which Recommendation for the diagnoses and treatment of Severe Asthma is the first listed.
NCT06389058 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06389058 about?
NCT06389058 is a clinical study titled "Using NLP and Neural Networks to Autonomously Identify Severe Asthma and Determine Study Eligibility in a Large Healthcare System". The study aims to to use new technologies (ML, AI, NLP), to autonomously identify moderate to severe asthma populations within an EHR system, describe differences in treatment patterns across different populations, and determine trial eligibility. Primary Objectives Please ensure you detail primary...
What is the current status of trial NCT06389058?
This trial is currently active not recruiting. The enrollment target is 31,795 participants. The study started on 2023-05-01. Estimated completion is 2026-03.
What conditions does trial NCT06389058 study?
This clinical trial studies the following conditions: Severe Asthma.
What interventions are being tested in trial NCT06389058?
The interventions under investigation include: Recommendation for the diagnoses and treatment of Severe Asthma (OTHER).
Who is sponsoring clinical trial NCT06389058?
This trial is sponsored by San Diego State University, which has 118 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06389058 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Severe Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06389058's enrollment target sits among peer trials
31,795 1st of 9 higher than 9 of 9 other Severe Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Severe Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Downstream Effects of Airway Mucus Plugs on 129Xenon MRI in Severe Asthma
RECRUITING
-
A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)
RECRUITING · Phase 2
-
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
RECRUITING · Phase 3
-
Phenotyping Asthma for Bronchial Thermoplasty
RECRUITING
-
Evaluation of Ventilation Defects Downstream of Mucus Plugs in Patients With Severe Asthma
RECRUITING
-
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07282665 · 32,000 participants · Phase 3
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
- NCT04477928 · 33,000 participants
General Population Level Estimation for Type 1 Diabetes Risk in Children During Routine Care Delivery
- NCT06145724 · 33,183 participants · NA
EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis (Aim 1)
- NCT00684580 · 30,000 participants
Protocol For Collecting Data On Patients With Childhood Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI